NO20042074L - Makrolider inneholdende farmasoytiske sammensetninger - Google Patents

Makrolider inneholdende farmasoytiske sammensetninger

Info

Publication number: NO20042074L
Authority: NO; Norway
Prior art keywords: pharmaceutical compositions; containing pharmaceutical; macrolides containing; macrolides; compositions
Prior art date: 2001-10-23

Application number

NO20042074A

Other languages

English (en)

Norwegian (no)

Inventor

Josef Gottried Meingassner

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-23

Filing date

2004-05-19

Publication date

2004-05-19

2001-11-14 Priority claimed from GB0127341A external-priority patent/GB0127341D0/en

2004-05-19 Application filed by Novartis Ag filed Critical Novartis Ag

2004-05-19 Publication of NO20042074L publication Critical patent/NO20042074L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Hematology (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Neurosurgery (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)
Transplantation (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Neurology (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

NO20042074A 2001-10-23 2004-05-19 Makrolider inneholdende farmasoytiske sammensetninger NO20042074L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB0125443.2A GB0125443D0 (en)	2001-10-23	2001-10-23	Organic Compounds
GB0127341A GB0127341D0 (en)	2001-11-14	2001-11-14	Organic compounds
PCT/EP2002/011799 WO2003035068A1 (en)	2001-10-23	2002-10-22	Macrolides containing pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
NO20042074L true NO20042074L (no)	2004-05-19

Family

ID=26246689

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20042074A NO20042074L (no)	2001-10-23	2004-05-19	Makrolider inneholdende farmasoytiske sammensetninger

Country Status (19)

Country	Link
US (1)	US7259170B2 (ru)
EP (1)	EP1439838A1 (ru)
JP (1)	JP2005509634A (ru)
KR (2)	KR20090114483A (ru)
CN (1)	CN1307993C (ru)
AU (1)	AU2002346859C1 (ru)
BR (1)	BR0213463A (ru)
CA (1)	CA2458690C (ru)
EC (1)	ECSP045086A (ru)
GB (1)	GB0125443D0 (ru)
HU (1)	HUP0402108A3 (ru)
IL (1)	IL160973A0 (ru)
MX (1)	MXPA04003738A (ru)
NO (1)	NO20042074L (ru)
NZ (1)	NZ532412A (ru)
PL (1)	PL368533A1 (ru)
RU (1)	RU2321402C2 (ru)
WO (1)	WO2003035068A1 (ru)
ZA (1)	ZA200401711B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1543345A (zh) *	2001-05-09	2004-11-03	诺瓦提斯公司	使用匹美莫司进行选择性免疫调节的方法
CN100406437C (zh)	2002-01-11	2008-07-30	三共株式会社	氨基醇衍生物或膦酸衍生物以及含有它们的药物组合物
GB0307867D0 (en) *	2003-04-04	2003-05-14	Novartis Ag	Pharmaceutical composition
AU2005215320B2 (en)	2004-02-24	2008-04-17	Sankyo Company, Limited	Amino alcohol compound

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0349061B1 (en)	1988-06-29	1995-03-29	Merck & Co. Inc.	Immunosuppressant agent
DE10299040I2 (de) *	1989-11-09	2006-08-24	Novartis Ag	Heteroatome enthaltende tricyclische Verbindungen
US5352671A (en) *	1989-11-09	1994-10-04	Sandoz Ltd.	Heteroatoms-containing tricyclic compounds
GB2252041A (en) *	1991-01-23	1992-07-29	Fujisawa Pharmaceutical Co	Use of macrolide compounds in treatment of autoimmune myocarditis
EP0576605A4 (en) *	1991-03-19	1994-06-08	Vithal J Rajadhyaksha	Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers
US5247076A (en) *	1991-09-09	1993-09-21	Merck & Co., Inc.	Imidazolidyl macrolides having immunosuppressive activity
GB9203636D0 (en) *	1992-02-19	1992-04-08	Lucas Ind Plc	Fuel pumping apparatus
DK0627406T3 (da)	1992-10-21	1999-07-12	Taito Co	2-Amino-1,3-propandiolforbindelser og immunundertrykkende midler
WO1994021642A1 (en)	1993-03-17	1994-09-29	Abbott Laboratories	Macrocyclic amide and urea immunomodulators
US5590460A (en) *	1994-07-19	1997-01-07	Tessera, Inc.	Method of making multilayer circuit
PT778263E (pt) *	1994-08-22	2002-06-28	Mitsubishi Pharma Corp	Composto de benzeno e sua utilizacao farmaceutica
GB9521322D0 (en)	1995-10-17	1995-12-20	Sandoz Ltd	Organic compounds
JPH11209277A (ja)	1998-01-19	1999-08-03	Yoshitomi Pharmaceut Ind Ltd	医薬組成物
GB9624038D0 (en) *	1996-11-19	1997-01-08	Sandoz Ltd	Organic compounds
NZ500713A (en) *	1997-04-04	2000-07-28	Yoshitomi Pharmaceutical	2-aminopropane-1,3-diol compounds and medicinal use thereof
GB9713730D0 (en) *	1997-06-30	1997-09-03	Ciba Geigy Ag	Organic compounds
JP4627356B2 (ja) *	1999-06-30	2011-02-09	昭松森	ウイルス性心筋炎の予防または治療薬剤
GB0003932D0 (en)	2000-02-18	2000-04-12	Novartis Ag	Pharmaceutical compositions
WO2002056790A2 (en)	2000-12-22	2002-07-25	Avantec Vascular Corporation	Delivery of therapeutic capable agents

2001
- 2001-10-23 GB GBGB0125443.2A patent/GB0125443D0/en not_active Ceased
2002
- 2002-10-22 KR KR1020097021354A patent/KR20090114483A/ko not_active Ceased
- 2002-10-22 EP EP02782975A patent/EP1439838A1/en not_active Withdrawn
- 2002-10-22 KR KR1020047005958A patent/KR100978971B1/ko not_active Expired - Fee Related
- 2002-10-22 HU HU0402108A patent/HUP0402108A3/hu unknown
- 2002-10-22 NZ NZ532412A patent/NZ532412A/en unknown
- 2002-10-22 PL PL02368533A patent/PL368533A1/xx not_active Application Discontinuation
- 2002-10-22 US US10/492,439 patent/US7259170B2/en not_active Expired - Fee Related
- 2002-10-22 MX MXPA04003738A patent/MXPA04003738A/es active IP Right Grant
- 2002-10-22 CN CNB028211588A patent/CN1307993C/zh not_active Expired - Fee Related
- 2002-10-22 JP JP2003537635A patent/JP2005509634A/ja active Pending
- 2002-10-22 WO PCT/EP2002/011799 patent/WO2003035068A1/en not_active Ceased
- 2002-10-22 CA CA2458690A patent/CA2458690C/en not_active Expired - Fee Related
- 2002-10-22 AU AU2002346859A patent/AU2002346859C1/en not_active Ceased
- 2002-10-22 IL IL16097302A patent/IL160973A0/xx unknown
- 2002-10-22 BR BR0213463-2A patent/BR0213463A/pt not_active IP Right Cessation
- 2002-10-22 RU RU2004116067/15A patent/RU2321402C2/ru not_active IP Right Cessation
2004
- 2004-03-02 ZA ZA200401711A patent/ZA200401711B/en unknown
- 2004-04-23 EC EC2004005086A patent/ECSP045086A/es unknown
- 2004-05-19 NO NO20042074A patent/NO20042074L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
MXPA04003738A (es)	2004-07-23
KR100978971B1 (ko)	2010-08-30
CN1307993C (zh)	2007-04-04
NZ532412A (en)	2006-01-27
AU2002346859B2 (en)	2006-03-02
CA2458690A1 (en)	2003-05-01
PL368533A1 (en)	2005-04-04
BR0213463A (pt)	2004-11-09
HUP0402108A3 (en)	2008-02-28
CA2458690C (en)	2011-01-25
US20040192716A1 (en)	2004-09-30
JP2005509634A (ja)	2005-04-14
GB0125443D0 (en)	2001-12-12
ZA200401711B (en)	2004-10-21
WO2003035068A1 (en)	2003-05-01
KR20090114483A (ko)	2009-11-03
HUP0402108A2 (hu)	2005-02-28
ECSP045086A (es)	2004-06-28
KR20040052250A (ko)	2004-06-22
US7259170B2 (en)	2007-08-21
RU2004116067A (ru)	2005-04-20
IL160973A0 (en)	2004-08-31
EP1439838A1 (en)	2004-07-28
RU2321402C2 (ru)	2008-04-10
CN1575173A (zh)	2005-02-02
AU2002346859C1 (en)	2008-07-10

Publication	Publication Date	Title
FI20011478A0 (fi)	2001-07-05	Farmaseuttinen koostumus
AR028204A1 (es)	2003-04-30	Composiciones farmaceuticas electrohiladas
FI20105657L (fi)	2010-06-10	Farmaseuttisia koostumuksia
ITMI20010748A0 (it)	2001-04-06	Composizioni farmaceutiche
DK1524266T3 (da)	2007-06-25	Farmaceutisk sammensætning
NO20033384L (no)	2003-09-25	Farmasoytisk formulering
NO20033556L (no)	2003-10-09	Farmasöytiske formuleringer
NO20033785L (no)	2003-10-24	Farmasöytisk formulering
AT7729U3 (de)	2006-01-15	Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat
EE200300589A (et)	2004-02-16	Ravimkoostised
DK1458377T3 (da)	2006-06-12	Farmaceutiske sammensætninger indeholdende tegaserod
NO20035627D0 (no)	2003-12-15	Farmasöytisk formulering
NO20026123L (no)	2003-02-18	Farmasöytiske sammensetninger
FI20022128L (fi)	2003-06-06	Farmaseuttinen koostumus
DK1425005T3 (da)	2006-09-04	Farmaceutisk sammensætning indeholdende lumiracoxib
NO20031095L (no)	2003-03-10	Farmasoytiske sammensetninger
ATE350016T1 (de)	2007-01-15	Bicalutamid enthaltende pharmazeutische zusammensetzung
NO20041485L (no)	2004-04-13	Farmasoytisk formulering omfattende (R)-bicalutamid
NO20042074L (no)	2004-05-19	Makrolider inneholdende farmasoytiske sammensetninger
ATE350029T1 (de)	2007-01-15	Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
EE200300465A (et)	2003-12-15	Püridoindolooni derivaatidel põhinevad farmatseutilised kompositsioonid
NO20033073D0 (no)	2003-07-04	Farmasöytisk sammensetning inneholdende citalopram
EE200200689A (et)	2004-06-15	Ravimkoostised
EP1413314A4 (en)	2004-12-22	MEDICAL COMPOSITIONS
FI5468U1 (fi)	2002-07-30	Farmaseuttinen koostumus

Legal Events

Date	Code	Title	Description
2010-05-31	FC2A	Withdrawal, rejection or dismissal of laid open patent application